Milczarek, S.; Kulig, P.; Baumert, B.; Łanocha, A.; Sommerfeld, K.; Borowiecka, E.; Osękowska, B.; Paczkowska, E.; Zdziarska, B.; Machaliński, B.
Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide. Medicina 2022, 58, 1350.
https://doi.org/10.3390/medicina58101350
AMA Style
Milczarek S, Kulig P, Baumert B, Łanocha A, Sommerfeld K, Borowiecka E, Osękowska B, Paczkowska E, Zdziarska B, Machaliński B.
Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide. Medicina. 2022; 58(10):1350.
https://doi.org/10.3390/medicina58101350
Chicago/Turabian Style
Milczarek, Sławomir, Piotr Kulig, Bartłomiej Baumert, Aleksandra Łanocha, Krzysztof Sommerfeld, Ewa Borowiecka, Bogumiła Osękowska, Edyta Paczkowska, Barbara Zdziarska, and Bogusław Machaliński.
2022. "Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide" Medicina 58, no. 10: 1350.
https://doi.org/10.3390/medicina58101350
APA Style
Milczarek, S., Kulig, P., Baumert, B., Łanocha, A., Sommerfeld, K., Borowiecka, E., Osękowska, B., Paczkowska, E., Zdziarska, B., & Machaliński, B.
(2022). Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide. Medicina, 58(10), 1350.
https://doi.org/10.3390/medicina58101350
